IKNA Annual Working Capital
$164.46 M
+$25.95 M+18.74%
31 December 2023
Summary:
As of January 23, 2025, IKNA annual working capital is $164.46 million, with the most recent change of +$25.95 million (+18.74%) on December 31, 2023. During the last 3 years, it has risen by +$26.82 million (+19.49%). IKNA annual working capital is now -21.44% below its all-time high of $209.33 million, reached on December 31, 2021.IKNA Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKNA Quarterly Working Capital
$132.29 M
-$8.83 M-6.26%
30 September 2024
Summary:
As of January 23, 2025, IKNA quarterly working capital is $132.29 million, with the most recent change of -$8.83 million (-6.26%) on September 30, 2024. Over the past year, it has dropped by -$49.07 million (-27.06%). IKNA quarterly working capital is now -47.76% below its all-time high of $253.22 million, reached on March 31, 2021.IKNA Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKNA Working Capital Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +18.7% | -27.1% |
3 y3 years | +19.5% | -11.0% |
5 y5 years | +170.0% | -11.0% |
IKNA Working Capital High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -21.4% | +18.7% | -36.8% | +4.0% |
5 y | 5-year | -21.4% | +170.0% | -47.8% | +4.0% |
alltime | all time | -21.4% | +170.0% | -47.8% | +4.0% |
Ikena Oncology Working Capital History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $132.29 M(-6.3%) |
June 2024 | - | $141.13 M(-6.5%) |
Mar 2024 | - | $151.00 M(-8.2%) |
Dec 2023 | $164.46 M(+18.7%) | $164.46 M(-9.3%) |
Sept 2023 | - | $181.36 M(+22.0%) |
June 2023 | - | $148.64 M(+16.8%) |
Mar 2023 | - | $127.23 M(-8.1%) |
Dec 2022 | $138.51 M | $138.51 M(-9.4%) |
Date | Annual | Quarterly |
---|---|---|
Sept 2022 | - | $152.94 M(-10.4%) |
June 2022 | - | $170.63 M(-10.5%) |
Mar 2022 | - | $190.72 M(-8.9%) |
Dec 2021 | $209.33 M(+52.1%) | $209.33 M(-5.4%) |
Sept 2021 | - | $221.29 M(-7.1%) |
June 2021 | - | $238.17 M(-5.9%) |
Mar 2021 | - | $253.22 M(+84.0%) |
Dec 2020 | $137.64 M(+126.0%) | $137.64 M |
Dec 2019 | $60.91 M | - |
FAQ
- What is Ikena Oncology annual working capital?
- What is the all time high annual working capital for Ikena Oncology?
- What is Ikena Oncology annual working capital year-on-year change?
- What is Ikena Oncology quarterly working capital?
- What is the all time high quarterly working capital for Ikena Oncology?
- What is Ikena Oncology quarterly working capital year-on-year change?
What is Ikena Oncology annual working capital?
The current annual working capital of IKNA is $164.46 M
What is the all time high annual working capital for Ikena Oncology?
Ikena Oncology all-time high annual working capital is $209.33 M
What is Ikena Oncology annual working capital year-on-year change?
Over the past year, IKNA annual working capital has changed by +$25.95 M (+18.74%)
What is Ikena Oncology quarterly working capital?
The current quarterly working capital of IKNA is $132.29 M
What is the all time high quarterly working capital for Ikena Oncology?
Ikena Oncology all-time high quarterly working capital is $253.22 M
What is Ikena Oncology quarterly working capital year-on-year change?
Over the past year, IKNA quarterly working capital has changed by -$49.07 M (-27.06%)